As of Feb 12
| +1.20 / +1.44%|
The 5 analysts offering 12-month price forecasts for Bio-Techne Corp have a median target of 100.00, with a high estimate of 107.00 and a low estimate of 92.00. The median estimate represents a +18.23% increase from the last price of 84.58.
The current consensus among 6 polled investment analysts is to Hold stock in Bio-Techne Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.